A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing

A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing

A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; including fever, shortness of breath, and coughing. This disease, now known as coronavirus disease 2019 (COVID-19), quickly spr...

Full description

Bibliographic Details
Main Authors: Maria T. Arévalo, Mark A. Karavis, Sarah E. Katoski, Jacquelyn V. Harris, Jessica M. Hill, Samir V. Deshpande, Pierce A. Roth, Alvin T. Liem, R. Cory Bernhards
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Microbiology
Subjects:
nanopore sequencing
COVID-19
SARS-CoV-2
whole genome sequencing
whole genome assembly
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.910955/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.910955/full

Similar Items